Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Research Article

Vol. 6 No. 1 (2001)

Ischemia Regulates Endoglin Expression in a Pig Skin Flap Model

DOI
https://doi.org/10.26443/mjm.v6i1.556
Submitted
November 6, 2020
Published
2020-12-01

Abstract

Endoglin is a transmembrane protein that binds transforming growth factor b (TGF-b) with high affinity. It is thought to modulate TGF-b signaling and responses through interactions on cell surfaces with TGF-b receptors. It is highly expressed on endothelial cells of tissues undergoing angiogenesis. Since ischemia-induced changes such as angiogenesis are in part regulated by TGF-b, it is important to elucidate the precise mechanism by which they occur if we are to influence the effects of ischemia on tissue. Since endoglin is one of the receptors involved in regulating TGF-b signaling, we tested whether endoglin expression will increase in response to ischemic injury. A pig skin flap model was developed and used in our laboratory to study the effect of ischemia on the expression of endoglin and its ligand TGF-b1 using immunohistochemistry. We observed an increased expression of endoglin and TGF-b1 in the epidermal layer, blood vessels, and fibroblasts in ischemic skin flaps as compared to non-ischemic control skin flaps. Given the role of TGF-b and endoglin in angiogenesis, this may represent a mechanism by which ischemia stimulates angiogenesis. Much work remains to be done to delineate the exact mechanisms by which TGF-b acts and the exact role of endoglin in TGF-b signaling. Understanding how to regulate the actions of TGF-b by manipulating the expression of endoglin may provide a therapeutic avenue given the importance of TGF-b in tumour angiogenesis.

References

  1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nature Medicine 1995; 1: 27-31.
  2. Kumar P. CD 105 and angiogenesis. Journal of Pathology 1996; 178: 363-366.
  3. Roberts AB, Sporn MB. Physiological actions and clinical applications of transforming growth factor-b (TGF-b). Growth Factors 1993; 8: 1-9.
  4. Roberts AB, Sporn MB, Assoian RK, et al. Transforming growth factor b: rapid induction of fibrosis and angiogenesis in vivo. Proceedings of the National Academy of Science USA 1986; 83: 4167-4171.
  5. Yang EY, Moses HL. Transforming growth factor b1-induced changes in cell migration, proliferation and angiogenesis in the chick choriallantoic membrane. Journal of Cell Biology 1990; 111: 731-741.
  6. Lefer AM, Ma XL, Weyrich AS, Scalia R. Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proceedings of the National Academy of Sciences USA 1993; 90: 1018-1022.
  7. McNeill H, Williams C, Guan J, et al. Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. Neuroreport 1994; 5: 901-904.
  8. Mehta JL, Yang BC, Strates BS, Mehta P. Role of TGF-b1 in platelet-mediated cardioprotection during ischemia-reperfusion in isolated rat hearts. Growth Factors. 1999; 16: 179-190.
  9. Miyazono K, Ten-Dijke P, Ichijo H, Heldin CH. Receptors for transforming growth factor-b. Advances in Immunology 1994; 55: 181-220.
  10. Massague J, Attisano L, Wrana JL. The TGF-b family and its composite receptors. Trends in Cell Biology 1994; 4: 172-178.
  11. Wrana JL, Attisano L, Wieser R, et al. Mechanism of activation of the TGF-b receptor. Nature 1994; 370: 341-347.
  12. ten Kijke T, Yamashita H, Ichijo H, et al. Characterization of type I receptors for transforming growth factor-beta and activin. Science 1994; 264: 101-104.
  13. Moustakas A, Lin HY, Henis YI, et al. The transforming growth factor beta receptors type I, II, and III form hetero-oligomeric complexes in the presence of ligand. Journal of Biological Chemistry 1993: 268: 22215-22218.
  14. Lopez-Casillas F, Wrana JL, Massague J. Betaglycan presents ligand to the TGF-b signaling receptor. Cell 1993; 73: 1435-1444.
  15. Gougos A, Letarte M. Primary structure of endoglin, an RGD- containing glycoprotein of human endothelial cells. Journal of Biological Chemistry 1990; 265: 8361 8364.
  16. Cheifetz S, Bellón T, Calés C, et al. Endoglin is a component of the transforming growth factor-b receptor system in human endothelial cells. Journal of Biological Chemistry 1992; 267: 19027-19030.
  17. Yamashita H, Ichijo H, Grimsby S, et al. Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-b. Journal of Biological Chemistry 1994; 269: 1995-2001.
  18. Lopez-Casillas F, Chiefetz S, Doody J, et al. Structure and expression of the membrane proteolgycan betaglycan, a component of the TGF-b receptor. Cell 1991; 67: 785-95
  19. Wang XF, Lin HY, Ng-Eaton E, et al. Expression, cloning and characterization of the TGF-b type III Receptor. Cell 1991; 67: 797-805.
  20. Letarte M, Breaves A, Vera S. CD 105 (endoglin). In: Scholossman SF et al., eds. Leucocyte Typing V. Oxford: Oxford University Press, 1995: 1756-1759.
  21. Westphal JR, Willems HW, Schalkwijk, CJM, et al. Characteristics and possible function of endoglin. A TGF-b binding protein. Behring Institute Mitteilungen 1993; 92: 15-22.
  22. Gougos A, St-jacques S, Greaves A, et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukaemic cells and syncytiotrophoblasts. International Immunology 1992: 4: 83-92.
  23. Krupinski J, Kumar P, Kumar S, Kaluza J. Increased expression of TGF-b1 in brain tissue after ischemic stroke in humans. Stroke 1996; 27: 852-857.
  24. Wang JM, Kumar S, Pye D, et al. Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. Journal of the National Cancer Institute 1994; 86: 386-388.
  25. Wang JM, Kumar S, van Agthoven AJ, et al. Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells. International Journal of Cancer 1995; 62: 791- 796.
  26. Lopez-Casillas F, Payne HM, Andres JL, Massague J. Betaglycan can act as a dual modulator of TGF-b access to signaling receptors: mapping of ligand binding and GAG attachment sites. Journal of Cell Biology 1994; 124: 557-568.
  27. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-b binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genetics 1994; 8: 345-351.
  28. McAllister KA, Baldwin MA, Thukkani AK, et al. Six additional mutations in the endoglin gene in HHT1 suggest a dominant-negative effect of receptor function. Human Molecular Genetics 1995; 4: 1983-1985.
  29. Picard-Ami LA Jr, Thomson JG, Kerrigan CL. Critical ischemia times and survival patterns of experimental pig flaps. Plastic and Reconstructive Surgery 1990; 86: 739 743.
  30. Conover WJ. Practical Nonparametric Statistics, 2nd ed. New York: Wiley, 1980.
  31. Lehmann EL. Nonparametrics: Statistical Methods Based on Ranks. San Francisco: Holden and Day, 1975.
  32. Letamendia A, Lastres P, Botella LM, et al. Role of endoglin in cellular responses to transforming growth factor-b. Journal of Biological Chemistry 1998; 273: 33011 33019.
  33. Lastres P, Letamendía A, Zhang H, et al. Endoglin modulates cellular responses to TGF-b1. Journal of Cell Biology 1996; 133: 1109-1121.
  34. Sutton AB, Canfield AE, Schor SL, et al. The response of endothelial cells to TGF-b1 is dependent upon cell shape, proliferative state and the nature of the substratum. Journal of Cell Science 1991; 99: 777-787.
  35. Klein-Soyer C, Archipoff G, Beretz A, Cazenave JP. Opposing effects of heparin with TGF-ß or aFGF during repair of a mechanical wound of human endothelium. Biology of the Cell 1992; 75: 155-162.
  36. Takashima S, Klagsbrun M. Inhibition of endothelial cell growth by macrophage-like U-937 cell-derived oncostatin M, leukemia inhibitory factor, and transforming growth factor b1. Journal of Biological Chemistry 1996; 271: 24901-24906.
  37. Li C, Hampson IN, Hampson L, et al. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells. FASEB Journal 2000; 14: 55-64.
  38. Li DY, Sorensen LK, Brook BS, et al. Defective angiogenesis in mice lacking endoglin. Science 1999; 284: 1534-1537.

Downloads

Download data is not yet available.